iBio (IBIO) Stock Jumps on Obesity Drug Momentum: All the Latest News, Analyst Targets and 2026–2027 Outlook (December 9, 2025)
As of December 9, 2025, iBio, Inc. (NASDAQ: IBIO) has turned into one of the louder tickers in the obesity‑drug corner of biotech. After closing Monday, December 8 at $1.67, up 39% on the day, IBIO is trading higher again in pre‑market action on Tuesday, with quotes between $1.76 and $1.81, pushing its market value to roughly $37–38 million.Benzinga The rally caps a run of pipeline, funding and analyst updates that have dramatically changed how the market is looking at this tiny, pre‑revenue biotech. Key takeaways for IBIO stock today This is still a high‑risk, preclinical nano‑cap, but it now